Study Summary
A study of CT-RD06 cell injection in patients with relapsed or refractory CD19+ B-cell hematological malignancy.
Want to learn more about this trial?
Request More InfoInterventions
CT-RD06BIOLOGICAL
CT-RD06 cell injection by intravenous infusion
Study Locations
| Facility | City | State | Country |
|---|---|---|---|
| The First Hospital of Zhejiang Medical Colleage Zhejiang University | Hangzhou | Zhejiang | China |